John Stoner, DO
Dermatology · York, PANPI 1225289408
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $705 and has fallen 53.6% since, to $327 in 2025. That places this record below the midpoint for dermatology clinicians in PA, where the typical reported total is $1,724.
Across 123 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$432
- Johnson & Johnson$310
- Sun Pharmaceutical Industries Inc.$229
- Amgen$214
- UCB, Inc.$133
- Lilly USA, LLC$131
- plus $723 from 11 others
What the payments were for
- Food & beverage$2,173100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $432 |
| Johnson & Johnson | 25 | $310 |
| Sun Pharmaceutical Industries Inc. | 8 | $229 |
| Amgen | 10 | $214 |
| UCB, Inc. | 6 | $133 |
| Lilly USA, LLC | 7 | $131 |
| Galderma Laboratories, L.p. | 7 | $117 |
| Bristol Myers Squibb | 6 | $97 |
| LEO Pharma Inc. | 7 | $84 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| Novartis | 4 | $80 |
| Dermira, Inc. | 3 | $51 |
| Aclaris Therapeutics, Inc. | 2 | $47 |
| Pfizer | 2 | $32 |
| Dermavant Sciences, Inc. | 2 | $30 |
| Strata Skin Sciences, Inc. | 2 | $25 |
How this compares
$2,173 in reported general payments places this provider in the 50th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 22 | $303,972 |
| Taltz AutoinjectorIxekizumab | 19 | $142,887 |
| OtezlaApremilast | 15 | $111,758 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $91,002 |
| Clobetasol Propionate | 150 | $6,194 |
| Doxycycline Hyclate | 110 | $5,327 |
| Ketoconazole | 253 | $4,805 |
| Betamethasone Dipropionate | 42 | $2,264 |
| Triamcinolone Acetonide | 260 | $2,206 |
| Famciclovir | 31 | $1,203 |
| Metronidazole | 27 | $1,090 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 36 | $988 |
| Doxycycline Monohydrate | 43 | $940 |
| Clindamycin Phosphate | 31 | $624 |
| Finasteride | 15 | $592 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $310 | $303,97222 claims |
| AmgenOtezla | $214 | $111,75815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 626 dermatology providers in Pennsylvania.
Other dermatology in York
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.